Meningococcal C and Quadrivalent Vaccines
Contract number CW2270374
Solicitation number WS3764597399
Contract award date
Expiry date
Amendment date
Amendment value CAD 2,339,993.28
Contract details
This contract was awarded to:
GlaxoSmithKline Inc.
Meningococcal C and Quadrivalent Vaccines
- Business address
-
100 Milverton Dr Suite 800Mississauga, Ontario, L5R 4H1CA
- Notice type
- Request for Proposal
- Procurement method
- Competitive – Open Bidding
- Language(s)
-
English,French
- Selection criteria
- Lowest Price
- Region(s) of delivery
-
Canada
Contract duration
The contract will be for a period of 24 month(s), from 2023/04/01 to 2025/03/31.
Total value of contract
This is the total value of this contract, which includes the initial contract value and the sum of all amendments.
CAD 5,957,012.52
Commodity - UNSPSC
- 51000000 - Drugs and Pharmaceutical Products
Trade agreements
-
Canadian Free Trade Agreement (CFTA)
-
Canada-Chile Free Trade Agreement (CCFTA)
-
Canada-Colombia Free Trade Agreement
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
World Trade Organization Agreement on Government Procurement (WTO GPA)
-
Canada-Honduras Free Trade Agreement
-
Canada-Korea Free Trade Agreement (CKFTA)
-
North American Free Trade Agreement (NAFTA)
-
Canada-Panama Free Trade Agreement
-
Canada-Peru Free Trade Agreement (CPFTA)
-
Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
-
Canada-Ukraine Free Trade Agreement (CUFTA)
-
Canada-UK Trade Continuity Agreement (Canada-UK TCA)
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
None
Contact information
Contracting organization
- Organization
-
Department of Public Works and Government Services (PSPC)
- Address
-
11 Laurier St, Phase III, Place du PortageGatineau, Quebec, K1A 0S5Canada
- Contracting authority
- Eady, Kasandra (SPAC/PSPC)
- Email
- kasandra.eady@tpsgc-pwgsc.gc.ca
Buying organization(s)
Related notices
Amendments made to this contract (1) A total of 1 amendments have been made to this contract. Click to collapse
This is a list of the amendments made to contract
CW2270374 that is awarded to GlaxoSmithKline Inc..
Amendment number
|
Contract value
|
Award date
|
|---|---|---|
| 000 | CAD 5 957 012.52 | 2023/01/25 |
Tender notices (1) This contract has 1 related tender notices. Click to collapse
|
Title
|
Solicitation Number
|
Publication date
|
Closing date
|
|---|---|---|---|
| Meningococcal C and Quadrivalent Vaccines | WS3764597399 | 2022/11/29 | 2022/12/20 |
Contracts awarded (3) This contract has 3 related award notices. Click to collapse
This is a list of other contracts that were awarded related to solicitation number WS3764597399. Click the link under “More details” to view the contract details.
|
Company name
|
Contract number
|
Amendment date
|
Award date
|
More details |
|---|---|---|---|---|
| Pfizer Canada ULC | CW2248827 | 2024/02/01 | 2023/01/25 | Viewthe details of contract CW2248827 for Pfizer Canada ULC |
| GlaxoSmithKline Inc. | CW2270374 | 2024/02/01 | 2023/01/25 | Viewthe details of contract CW2270374 for GlaxoSmithKline Inc. |
| Sanofi Pasteur Limited | CW2270377 | 2024/01/29 | 2023/01/25 | Viewthe details of contract CW2270377 for Sanofi Pasteur Limited |
Contract history (7) This contract has 7 related contracts. Click to collapse
This is a list of other contracts that were awarded and their amendments. Click the link under “More details” to view the contract details.
|
Company name
|
Contract number
|
Amendment number
|
Award date
|
More details |
|---|---|---|---|---|
| Pfizer Canada ULC | CW2248827 | 002 | 2023/01/25 | Viewthe details of contract CW2248827 for Pfizer Canada ULC |
| Sanofi Pasteur Limited | CW2270377 | 002 | 2023/01/25 | Viewthe details of contract CW2270377 for Sanofi Pasteur Limited |
| Sanofi Pasteur Limited | CW2270377 | 001 | 2023/01/25 | Viewthe details of contract CW2270377 for Sanofi Pasteur Limited |
| Pfizer Canada ULC | CW2248827 | 001 | 2023/01/25 | Viewthe details of contract CW2248827 for Pfizer Canada ULC |
| GlaxoSmithKline Inc. | CW2270374 | 000 | 2023/01/25 | Viewthe details of contract CW2270374 for GlaxoSmithKline Inc. |
| Sanofi Pasteur Limited | CW2270377 | 000 | 2023/01/25 | Viewthe details of contract CW2270377 for Sanofi Pasteur Limited |
| Pfizer Canada ULC | CW2248827 | 000 | 2023/01/25 | Viewthe details of contract CW2248827 for Pfizer Canada ULC |
